Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are PPOs a competitive force or antitrust risk?

R J Enders

    Healthcare Financial Management : Journal of the Healthcare Financial Management Association
    |April 10, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    PHOs undergo new level of antitrust scrutiny.

    California hospitals·1996
    Same author

    Antitrust law in 1995: mixed messages for providers.

    Health systems review·1996
    Same author

    Physician organizations: two years under the FTC/DOJ guidelines.

    Health care law newsletter·1995
    Same author

    Special report on antitrust. Antitrust implications of physician practice affiliations and acquisitions: a question of market power, Part I.

    Health care law newsletter·1995
    Same author

    The joint venture alternative to mergers.

    Health care law newsletter·1995
    Same author

    New antitrust enforcement policy statements issued for health care providers.

    Health care law newsletter·1994

    Preferred Provider Organizations (PPOs) are encouraged in healthcare for competition, but pose antitrust risks. While lawsuits are rare, the potential for future legal challenges remains significant.

    Area of Science:

    • Healthcare Economics
    • Antitrust Law

    Background:

    • Preferred Provider Organizations (PPOs) are increasingly promoted as a means to foster competition within the healthcare market.
    • This trend is accompanied by concerns regarding potential violations of antitrust regulations.

    Purpose of the Study:

    • To analyze the dual nature of PPOs as both procompetitive tools and potential antitrust liabilities.
    • To assess the current landscape and future implications of antitrust scrutiny on PPOs.

    Main Methods:

    • Review of existing literature on PPO formation and market impact.
    • Analysis of antitrust case law and regulatory guidance related to healthcare networks.
    • Discussion of market dynamics and competitive pressures influencing PPO development.

    Related Experiment Videos

    Main Results:

    • PPOs are recognized for their potential to enhance market competition.
    • Despite a low number of filed lawsuits, the risk of antitrust violations persists.
    • PPOs represent a significant element in contemporary healthcare, likely to face increased antitrust challenges.

    Conclusions:

    • The procompetitive benefits of PPOs must be carefully weighed against potential antitrust risks.
    • Ongoing monitoring and legal analysis are crucial for navigating the regulatory landscape of PPOs.
    • The evolving role of PPOs in healthcare necessitates a proactive approach to antitrust compliance.